Sedik, Sarah
Boyer, Johannes
Egger, Matthias
Dichtl, Karl
Prattes, Juergen
Prüller, Florian
Hoenigl, Martin http://orcid.org/0000-0002-1653-2824
Funding for this research was provided by:
IMMY Investigator Initiated Research
Medical University of Graz
Article History
Received: 18 April 2024
Accepted: 4 July 2024
First Online: 18 July 2024
Declarations
:
: M.H. received research funding from Gilead, Astellas, MSD, IMMY, Pulmocide, Shionogi, Melinta, Mundipharma, Scynexis, F2G and Pfizer, all unrelated to the submitted work. J.P. holds the position of President at the Austrian Society of Medical Mycology, received speaker fees from Gilead, Pfizer, Swedish Orphan BioVitrum, Associates of Cape Cod and is stockholder of AbbVie Inc. and Novo Nordisk—all outside of the submitted work. K.D. received research funding from Euroimmun Medizinische Labordiagnostika and FUJUFILM Wako Chemicals Europe outside of the submitted work. All other authors declare no conflict of interest for this study.